(Q38244027)

31 August 2017

title

Scoring of chest CT in children with cystic fibrosis: state of the art. (English)

1 reference

31 August 2017

0 references

1 reference

Alistair D Calder

1

1 reference

31 August 2017

Andrew Bush

series ordinal

2

1 reference

31 August 2017

Alan S Brody

series ordinal

3

1 reference

31 August 2017

Catherine M Owens

series ordinal

4

1 reference

31 August 2017

publication date

28 August 2014

1 reference

31 August 2017

1 reference

31 August 2017

volume

44

1 reference

31 August 2017

issue

12

1 reference

31 August 2017

page(s)

1496-1506

1 reference

High-resolution computed tomography in young patients with cystic fibrosis: distribution of abnormalities and correlation with pulmonary function tests

31 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00247-013-2867-Y

Bronchiectasis in infants and preschool children diagnosed with cystic fibrosis after newborn screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00247-013-2867-Y

The spectrum of structural abnormalities on CT scans from patients with CF with severe advanced lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00247-013-2867-Y

Statistical techniques for comparing measurers and methods of measurement: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00247-013-2867-Y

Computed tomography reflects lower airway inflammation and tracks changes in early cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00247-013-2867-Y

Use of computerized tomography and chest x-rays in evaluating efficacy of aerosolized recombinant human DNase in cystic fibrosis patients younger than age 5 years: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00247-013-2867-Y

High resolution computerized tomography of the chest and pulmonary function testing in evaluating the effect of tobramycin solution for inhalation in cystic fibrosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00247-013-2867-Y

Reproducibility of a scoring system for computed tomography scanning in cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00247-013-2867-Y

Pulmonary disease assessment in cystic fibrosis: comparison of CT scoring systems and value of bronchial and arterial dimension measurements

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00247-013-2867-Y

Chest computed tomography: a validated surrogate endpoint of cystic fibrosis lung disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00247-013-2867-Y

Cystic fibrosis specific computed tomography scoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00247-013-2867-Y

Structural airway abnormalities in infants and young children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00247-013-2867-Y

Progression of lung disease on computed tomography and pulmonary function tests in children and adults with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00247-013-2867-Y

Impact of bronchiectasis and trapped air on quality of life and exacerbations in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00247-013-2867-Y

Biomarkers and surrogate end points--the challenge of statistical validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00247-013-2867-Y

Biomarkers and surrogate markers: an FDA perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00247-013-2867-Y

Use of lung imaging studies as outcome measures for development of new therapies in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00247-013-2867-Y

Progressive damage on high resolution computed tomography despite stable lung function in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00247-013-2867-Y

Multiple-breath inert gas washout and spirometry versus structural lung disease in cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00247-013-2867-Y

Chest computed tomography scores of severity are associated with future lung disease progression in children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00247-013-2867-Y

Differences in the pattern of structural abnormalities on CT scan in patients with cystic fibrosis and pancreatic sufficiency or insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00247-013-2867-Y

Lung disease at diagnosis in infants with cystic fibrosis detected by newborn screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00247-013-2867-Y

Chest computed tomography scores are predictive of survival in patients with cystic fibrosis awaiting lung transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00247-013-2867-Y

Computed tomography correlates with pulmonary exacerbations in children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00247-013-2867-Y

Bronchiectasis and pulmonary exacerbations in children and young adults with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00247-013-2867-Y

Prospective evaluation of respiratory exacerbations in children with cystic fibrosis from newborn screening to 5 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00247-013-2867-Y

Changes in physiological, functional and structural markers of cystic fibrosis lung disease with treatment of a pulmonary exacerbation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00247-013-2867-Y

Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis: a multicenter, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00247-013-2867-Y

Dornase alfa reduces air trapping in children with mild cystic fibrosis lung disease: a quantitative analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00247-013-2867-Y

Composite Spirometric–Computed Tomography Outcome Measure in Early Cystic Fibrosis Lung Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00247-013-2867-Y

An official American Thoracic Society/European Respiratory Society statement: pulmonary function testing in preschool children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00247-013-2867-Y

General considerations for lung function testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00247-013-2867-Y

Standardisation of spirometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00247-013-2867-Y

Standardisation of the single-breath determination of carbon monoxide uptake in the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00247-013-2867-Y

Standardisation of the measurement of lung volumes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00247-013-2867-Y

Interpretative strategies for lung function tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00247-013-2867-Y

Air Trapping at CT: High Prevalence in Asymptomatic Subjects with Normal Pulmonary Function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00247-013-2867-Y

Bronchoarterial ratio and bronchial wall thickness on high-resolution CT in asymptomatic subjects: correlation with age and smoking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00247-013-2867-Y

Distribution of early structural lung changes due to cystic fibrosis detected with chest computed tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00247-013-2867-Y

Fleischner Society: glossary of terms for thoracic imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00247-013-2867-Y

Progression of early structural lung disease in young children with cystic fibrosis assessed using CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00247-013-2867-Y

Computed tomography scanning techniques for the evaluation of cystic fibrosis lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00247-013-2867-Y

An automated approach to quantitative air trapping measurements in mild cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00247-013-2867-Y

Assessment of early bronchiectasis in young children with cystic fibrosis is dependent on lung volume

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00247-013-2867-Y

Chest computed tomography scans should be considered as a routine investigation in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00247-013-2867-Y

Radiologic imaging in cystic fibrosis: cumulative effective dose and changing trends over 2 decades.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00247-013-2867-Y

Dependence of Weighted Kappa Coefficients on the Number of Categories

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00247-013-2867-Y

Cystic fibrosis: scoring system with thin-section CT

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00247-013-2867-Y

Bronchial measurement with three-dimensional quantitative thin-section CT in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00247-013-2867-Y

Bronchoarterial Ratio on High-Resolution CT Scan of the Chest in Children Without Pulmonary Pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00247-013-2867-Y

The use of high resolution computerized tomography (HRCT) of the chest in evaluating the effect of tobramycin solution for inhalation in cystic fibrosis lung disease

21 January 2018

1 reference

12 December 2020

High-resolution computed tomography of the chest in children with cystic fibrosis: support for use as an outcome surrogate

1 reference

12 December 2020

High resolution CT in children with cystic fibrosis: correlation with pulmonary functions and radiographic scores

1 reference

12 December 2020

Lung Clearance Index and HRCT are complementary markers of lung abnormalities in young children with CF

1 reference

12 December 2020

Sensitivity of Lung Clearance Index and chest computed tomography in early CF lung disease

1 reference

12 December 2020

High-resolution CT in the acute exacerbation of cystic fibrosis: evaluation of acute findings, reversibility of those findings, and clinical correlation

1 reference

12 December 2020

Criteria for judging precision and accuracy in method development and evaluation

1 reference

12 December 2020

Image analysis for cystic fibrosis: automatic lung airway wall and vessel measurement on CT images

1 reference

12 December 2020

10.1007/S00247-013-2867-Y

Identifiers

DOI

1 reference

Dimensions Publication ID

31 August 2017

1019506218

0 references

1 reference